Data Foundry

Drug recalls 2023

Lidocaine Hydrochloride Jelly USP — Class II drug recall D-0143-2023

Ongoing recall by Akorn, Inc., reported 2023-01-25, distributed nationwide. CGMP Deviations:

Recall numberD-0143-2023
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAkorn, Inc., Gurnee, IL, United States
Recall initiated2022-10-13
Classified2023-01-13
Reported by FDA2023-01-25
DistributedNationwide (US)
Quantity2,369,258 tubes
Reason classescgmp
NDC17478-0711-10, 17478-0711-30, 17478-0711-31
Lot numbers0A02A, 0A02B, 0A02C, 0A02D, 0A02E, 0A06A, 0A37A, 0B44A, 0B46A, 0B46B, 0B46D, 0B60A, 0B60B, 0B60C, 0B60D, 0B67A, 0B67B, 0B67C, 0B67D, 0C78B, 0C78C, 0C78D, 0C84A, 0C88A, 0D08A, 0D11A, 0D11B, 0D11C, 0D11D, 0D21A, 0E31A, 0E35A, 0E35B, 0E35C, 0E46A, 0E46B, 0E48A, 0F58A, 0F72A, 0G05A and 69 more
Expiration dates2022-12-31, 2023-01-31, 2023-02-28, 2023-03-31, 2023-04-30, 2023-05-31, 2023-06-30, 2023-07-31, 2023-08-31, 2023-09-30, 2023-10-31, 2024-01-31, 2024-02-29, 2024-03-31, 2024-06-30, 2024-07-31, 2024-08-31, 2024-09-30, 2024-10-31, 2025-02-28, 2025-03-31

Product

Lidocaine Hydrochloride Jelly USP, 2%, Packaged as (a) 5 mL tube (NDC 17478-711-10) x10 per box NDC 17478-711-31; (b) 30 mL tube NDC 17478-711-30; Rx only, Manufactured by: Akorn, Inc., Lake Forest, Il 60045.

Reason for recall

CGMP Deviations:

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0143-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.